Attention Deficit-hyperactivity Disorder Clinical Trial
Official title:
Improving the Medication Management of Patients With Attention-Deficit Hyperactivity Disorder
The specific aim of this cluster-randomized (site) comparative effectiveness research study is to determine whether children who are (1) 5-12 years of age, (2) cared for in ePROS practices or clinics using an electronic health record (EHR), (3) have attention-deficit hyperactivity disorder (ADHD), and (4) are to receive treatment with stimulant medication for the first time in these practices, have superior clinical outcomes if their clinicians have access to an EHR-guided clinical decision support system (intervention group) than if their clinicians have no such access (control group).
In this cluster (site)-randomized trial of clinical decision support for ADHD medication
titration, clinicians caring for children with ADHD whose families are initiating stimulant
medication at that practice will be followed.
Two groups will be compared; an intervention group, which will receive the intervention—the
clinical decision support (CDS)--, and a control group, who will not receive CDS. Over a
6-month period, the CDS will support guideline-based medication titration to achieve optimal
symptom control with minimal side effects. The study will track the care delivered to
affected children by the practitioners and will assess the endpoints of symptom reduction and
side effects. There will also be a sub-study within the larger study which will give the team
a better understanding about the pros and cons of consenting parents over the phone.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04152629 -
Real World Evidence of the Efficacy and Safety of FOQUEST
|
Phase 4 | |
Completed |
NCT03003286 -
Community Based Intervention for Children With ADHD and ASD
|
N/A | |
Recruiting |
NCT04038073 -
TLR Polymorphism, ASO and Beta-hemolytic Group A Streptococcus Infections in ADHD: an Observational Study
|
||
Completed |
NCT01831622 -
Influence of Stimulant Medication on Brain Processes for Decision Making in Attention Deficit Hyperactivity Disorder
|
Phase 4 | |
Completed |
NCT03847402 -
The Early Integrated Intervention for Child Brain-developmental Disorders in China
|
N/A | |
Completed |
NCT03440346 -
Biomarker Research in ADHD: the Impact of Nutrition
|
N/A | |
Completed |
NCT04689282 -
Intranasal Inhalations of M2 Macrophage Soluble Factors in Children With Developmental Speech Disorders
|
Phase 1/Phase 2 | |
Recruiting |
NCT02778360 -
Effectiveness of a Personalized Neurofeedback Training Device (ADHD@Home) in Attention-Deficit/Hyperactivity Disorder
|
Phase 1/Phase 2 | |
Completed |
NCT04228094 -
Assesment of TDApp1 an eHelath Tool to Make Therapeutic Recommendations for Patients With ADHD
|